Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02UOZ
|
|||
| Former ID |
DIB001564
|
|||
| Drug Name |
NB-001
|
|||
| Synonyms |
NanoHPX; Herpes labialis therapy (NanoStat topical formulation), NanoBio; Herpes simplex virus type 1 (HSV-1) therapy (NanoStat topical formulation), NanoBio
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Multiple sclerosis [ICD-11: 8A40] | Phase 3 | [1] | |
| Company |
Nanobio
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H20N6O
|
|||
| Canonical SMILES |
C1=NC(=C2C(=N1)N(C=N2)CCNCCCCCO)N
|
|||
| InChI |
1S/C12H20N6O/c13-11-10-12(16-8-15-11)18(9-17-10)6-5-14-4-2-1-3-7-19/h8-9,14,19H,1-7H2,(H2,13,15,16)
|
|||
| InChIKey |
CVPTTZZCRDVGSU-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 686301-48-4
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01695187) NB-001 Treatment of Recurrent Herpes Labialis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.